Eltrombopag for the treatment of refractory thrombocytopenia associated with connective tissue disease

Abstract To assess the efficacy and safety of eltrombopag in connective tissue disease (CTD)-immune thrombocytopenia (ITP), we conducted this single-center retrospective observational study, including patients with refractory CTD-ITP who were treated with eltrombopag between January 2018 and August...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Wang, Min Dai, Qiong Fu, Sheng Chen
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/efe7af08d0f3455089981a6d8628972c
Tags: Add Tag
No Tags, Be the first to tag this record!